Related Experiment Videos
LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration
1John P. Robarts Research Institute, London, Ontario, Canada. robert.hegele@rri.on.ca
The Journal of Clinical Endocrinology and Metabolism
|September 22, 2000
Summary
The LMNA R482Q mutation significantly impacts plasma leptin and insulin levels in familial partial lipodystrophy (FPLD). This rare mutation affects leptin concentration, independent of body mass index, influencing metabolic markers in FPLD patients.
Area of Science:
- Genetics
- Metabolic Disorders
- Cell Biology
Background:
- Familial partial lipodystrophy (FPLD) is linked to mutations in the LMNA gene, encoding lamins A and C.
- The LMNA R482Q mutation is a rare genetic variant associated with FPLD.
Purpose of the Study:
- To investigate the relationship between the LMNA R482Q mutation and plasma leptin levels in adult FPLD subjects.
- To determine the impact of the LMNA R482Q genotype on metabolic parameters including leptin, insulin, and C-peptide.
Main Methods:
- Analysis of plasma leptin, leptin to body mass index (BMI) ratio, insulin, and C-peptide in 23 adult FPLD subjects with the LMNA R482Q mutation and 25 family controls.
- Genotyping for the LMNA R482Q mutation.
- Multivariate regression analysis to assess the contribution of the LMNA R482Q genotype to variations in metabolic markers.
Main Results:
- The LMNA R482Q genotype significantly determined plasma leptin, leptin:BMI ratio, plasma insulin, and plasma C-peptide levels.
- Heterozygosity for LMNA Q482/R482 was associated with lower plasma leptin and leptin:BMI ratio compared to unaffected homozygotes.
- LMNA Q482/R482 heterozygotes exhibited higher fasting plasma insulin and C-peptide concentrations than R482/R482 homozygotes.
- The LMNA R482Q genotype accounted for a substantial proportion of the variation in leptin, leptin:BMI ratio, insulin, and C-peptide.
Conclusions:
- A rare FPLD mutation in LMNA is a significant determinant of plasma leptin concentration.
- The study suggests a link between the LMNA R482Q mutation and altered insulin and leptin metabolism in FPLD.
- Further research is needed to elucidate whether reduced leptin or insulin resistance are direct consequences of the mutant LMNA or secondary to adipose tissue changes.